Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 699 23 579.0 |
96 | EP file number | EAKZ | 99 97 1797.8 |
86 | WO file number | WAKZ | PCT/EP99/08577 |
97 | EP publication number | EPN | 1129066 |
87 | WO publication number | WPN | 2000027798 |
54 | Designation/title | TI | HERSTELLUNG VON 2-AMINO-2(2-(4-ALKYLPHENYL)ÄTHYL)PROPAN-1,3-DIOLEN |
51 | IPC main class | ICM (ICMV) | C07C 215/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07C 213/08 (2006.01), C07C 22/04 (2006.01) |
22 | DE application date | DAT | Nov 9, 1999 |
96 | EP application date | EAT | Nov 9, 1999 |
86 | WO application date | WAT | Nov 9, 1999 |
43 | Date of first publication | OT | May 18, 2000 |
| Date of publication of grant | PET | Feb 2, 2005 |
71/73 | Applicant/owner | INH | Novartis AG, 4056 Basel, CH; Taito Co., Ltd., Tokio/Tokyo, JP; Mitsubishi Pharma Corp., Osaka, JP |
72 | Inventor | IN | ABEL, Stephan, W-7957 Weil, DE; FUJITA, Tetsuro, Muko-shi, Kyoto 617-0004, JP; HIROSE, Ryoji, Akashi, Hyogo 673-0003, JP; JORDINE, Guido, W-7910 Freiburg, DE; MISHINA, Tadashi, Hirakata-shi, Osaka 573-1105, JP |
10 | Published DE documents | DEPN | Original document:
DE000069923579T2 Searchable text:
DE000069923579T2 |
| Address for service | | Novartis AG, 4056 BASEL, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 9824706 Nov 11, 1998
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 9824705 Nov 11, 1998
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000001129066 Searchable text:
EP000001129066 Original document:
EP000001129066B1 Searchable text:
EP000001129066B1 Original document:
WO002000027798 Searchable text:
WO002000027798 |
43 | Date of first publication | EVT | May 18, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2025 (Show all update days)(Hide all update days)- Jan 5, 2025
- Procedures: New representative details, New representative details, 19.03.2014: changed
- Nov 12, 2019; Nov 17, 2018; Oct 30, 2018; Nov 16, 2017; Nov 23, 2016; Nov 18, 2015; Aug 25, 2015; Nov 25, 2014; Mar 20, 2014; Dec 11, 2013; Nov 21, 2013; Jan 23, 2013; Dec 6, 2012; Nov 21, 2012
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Dec 28, 2004 |
71/73 | Applicant/owner | INH | Novartis AG, 4056 Basel, CH; Taito Co., Ltd., Tokio/Tokyo, JP; Mitsubishi Pharma Corp., Osaka, JP |
71/73 | Previous applicant/owner | INHF | Novartis AG, 4056 Basel, CH, Novartis-Erfindungen Verwaltungsgesellschaft m.b.H., Wien, AT, Taito Co., Ltd., Tokio/Tokyo, JP, Welfide Corp., Osaka, JP |